GnRH agonist treatment for precocious puberty

GnRH agonists can pause hormone-driven puberty after a clinician confirms that early pubertal changes are progressing. They act on the brain-to-pituitary signal that stimulates the ovaries or testes, helping reduce the release of sex hormones while treatment continues.

Precocious puberty refers to pubertal development that begins earlier than expected. A specialist may assess growth pattern, physical changes, bone maturity, and hormone results before discussing treatment. A female hormone blood panel may be one part of that assessment. The goal is to slow further hormone effects and give the child more time to grow and adjust. The medicine may be given as an injection or another prescribed formulation, with the schedule chosen by the treating team.

Keep appointments so the clinician can review height, growth rate, physical development, and any treatment reactions. Record the date of each dose and mention headaches, mood changes, injection-site swelling, or new symptoms. Do not change or stop the schedule without guidance, because the hormone signal may return when doses are delayed. Support the child with calm, age-appropriate explanations and invite questions about body changes.

Contact the treating team promptly for severe or persistent headache, vision changes, marked vomiting, breathing difficulty, facial swelling, or a rapidly worsening reaction after a dose. Seek urgent help for fainting, seizure, or trouble breathing. A new pubertal change between visits also deserves review, especially when a dose was missed or delayed.

Ask which findings support treatment, how the medicine will be administered, when progress will be checked, what to do after a missed dose, and which reactions need same-day advice. You can also ask how treatment may affect school, activities, mood, and the timing of follow-up after it ends.